(MDXG) MiMedx - Performance -6.6% in 12m
MDXG performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
7.09%
#28 in Peer-Group
Rel. Strength
30.74%
#5316 in Stock-Universe
Total Return 12m
-6.63%
#70 in Peer-Group
Total Return 5y
17.41%
#31 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 22.0 |
| P/E Forward | 19.5 |
| High / Low | USD |
|---|---|
| 52 Week High | 9.75 USD |
| 52 Week Low | 5.51 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 76.69 |
| Buy/Sell Signal +-5 | 1.25 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: MDXG (-6.6%) vs XBI (-7%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.23% | 73% | 77.8% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.1% | -6.38% | 147% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
3.91% | -0.97% | 36% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
1.34% | 27.6% | -4.82% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.69% | -7.17% | 1.14% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
18.3% | 43% | -4.19% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.03% | 58.7% | -9.25% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
6.2% | 28.7% | 15.2% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: MDXG vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for MDXG
| Total Return (including Dividends) | MDXG | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -1.25% | 3.36% | 5.25% |
| 3 Months | -10.20% | 15.73% | 24.13% |
| 12 Months | -6.63% | -7.02% | 14.15% |
| 5 Years | 17.41% | -24.21% | 111.83% |
| Trend Score (consistency of price movement) | MDXG | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -44.1% | 4.4% | 81% |
| 3 Months | -73.4% | 78.8% | 96.9% |
| 12 Months | 8.8% | -85.8% | 44.9% |
| 5 Years | 1.7% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th49.00 | -4.45% | -6.17% |
| 3 Month | %th18.50 | -22.40% | -27.65% |
| 12 Month | %th66.00 | 0.43% | -18.20% |
| 5 Years | %th85.50 | 54.91% | -44.58% |
FAQs
Does MiMedx (MDXG) outperform the market?
Yes,
over the last 12 months MDXG made -6.63%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.02%.
Over the last 3 months MDXG made -10.20%, while XBI made 15.73%.
Performance Comparison MDXG vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
MDXG vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 5% | -6.5% | -34.5% | -21% |
| US NASDAQ 100 | QQQ | 5.3% | -6.6% | -35.2% | -19% |
| German DAX 40 | DAX | 7.2% | 0.2% | -46.7% | -36% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 5.2% | -4.5% | -37.9% | -27% |
| Hongkong Hang Seng | HSI | 5.4% | -7.3% | -54% | -45% |
| India NIFTY 50 | INDA | 6.9% | -4.7% | -34.8% | -6% |
| Brasil Bovespa | EWZ | 2.6% | -10.1% | -59.6% | -17% |
MDXG vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 6.4% | -7.2% | -38.6% | -31% |
| Consumer Discretionary | XLY | 5.5% | -4.4% | -26.9% | -25% |
| Consumer Staples | XLP | 4.7% | -1.9% | -36.2% | -16% |
| Energy | XLE | 4.7% | -8.3% | -30.4% | -6% |
| Financial | XLF | 4.3% | -6.3% | -39.4% | -37% |
| Health Care | XLV | 5.6% | -3.4% | -27.2% | -2% |
| Industrial | XLI | 4.9% | -5.5% | -42.4% | -32% |
| Materials | XLB | 2.8% | -5.5% | -39% | -13% |
| Real Estate | XLRE | 5.1% | -2.2% | -34.2% | -19% |
| Technology | XLK | 4.3% | -9.9% | -36.8% | -18% |
| Utilities | XLU | 6.1% | -3% | -37.7% | -30% |
| Aerospace & Defense | XAR | 7.2% | -8.3% | -53.1% | -56% |
| Biotech | XBI | 4% | -4.6% | -21.3% | 0% |
| Homebuilder | XHB | 2.5% | -8.3% | -27.3% | -12% |
| Retail | XRT | 2.5% | -6.2% | -30.2% | -18% |
MDXG vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 4.1% | -9.69% | -26.1% | 1% |
| Natural Gas | UNG | 14.5% | 8.6% | -17.7% | -4% |
| Gold | GLD | 4.8% | -0% | -55.1% | -46% |
| Silver | SLV | 4% | -8.2% | -51.9% | -24% |
| Copper | CPER | 6% | -5.8% | -51.6% | -18% |
MDXG vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 6.8% | -2.3% | -31.1% | -5% |
| iShares High Yield Corp. Bond | HYG | 6.2% | -2.9% | -33.4% | -17% |